Haemophilia Treatment Market - Global Industry Size, Share, Trends, Opportunity and Forecast 2026 | TechSci Research

1
2016 2026
GLOBAL HAEMOPHILIA TREATMENT MARKET FORECAST
OPPORTUNITIES
2

• Scope of Report
• Product of Interest (POI) Haemophilia Treatment

Hemophilia is treated with replacement therapy .
This involves giving or replacing the clotting
factors that are too low or missing in a patient
with the condition. Patients receive clotting
factors by injection or intravenously.
Market Segmentation
TYPE

• Haemophilia A
• Haemophilia B
• Haemophilia C

PRODUCT

• Recombinant Coagulation Factor Concentrates
• Plasma Derived Coagulation Factor Concentrate
• Desmopressin
• Antifibrinolytics Agents

TREATMENT

• On-demand
• Prophylaxis

THERAPY

• Replacement Therapy
• ITI Therapy
• Gene Therapy

3

• Table of Contents

S. No. Contents Contents Contents Page No.
1. Product Overview (Definition of Product Type and major terminologies used in the report) Product Overview (Definition of Product Type and major terminologies used in the report) Product Overview (Definition of Product Type and major terminologies used in the report)
2. Research Methodology (Detailed description of the methodology used to conduct the research, Raw data backup, list of all secondary sources, List of respondents for primary surveys) Research Methodology (Detailed description of the methodology used to conduct the research, Raw data backup, list of all secondary sources, List of respondents for primary surveys) Research Methodology (Detailed description of the methodology used to conduct the research, Raw data backup, list of all secondary sources, List of respondents for primary surveys)
3. Impact of COVID-19 on Global Haemophilia Treatment Market Impact of COVID-19 on Global Haemophilia Treatment Market Impact of COVID-19 on Global Haemophilia Treatment Market
4. Executive Summary (This chapter covers summary of the complete study.) Executive Summary (This chapter covers summary of the complete study.) Executive Summary (This chapter covers summary of the complete study.)
5. Voice Of Customer Voice Of Customer Voice Of Customer
5.1. Brand Awareness Brand Awareness
5.2. Unmet Needs Challenges Unmet Needs Challenges
5.3. Factors Influencing Drug Purchase Factors Influencing Drug Purchase
6. Global Haemophilia Treatment Market Outlook, 2016-2026F (This chapter includes a brief overview of the product of interest market such as total markets growth rate, expected growth rate, key growth levers, leading region, top grossing product types, etc. It includes more of a qualitative information about the market.) Global Haemophilia Treatment Market Outlook, 2016-2026F (This chapter includes a brief overview of the product of interest market such as total markets growth rate, expected growth rate, key growth levers, leading region, top grossing product types, etc. It includes more of a qualitative information about the market.) Global Haemophilia Treatment Market Outlook, 2016-2026F (This chapter includes a brief overview of the product of interest market such as total markets growth rate, expected growth rate, key growth levers, leading region, top grossing product types, etc. It includes more of a qualitative information about the market.)
6.1. Market Size Forecast Market Size Forecast
6.1.1. By Value
6.2. Market Share Forecast Market Share Forecast
6.2.1. By Type (Haemophilia A, Haemophilia B, Haemophilia C) By Type (Haemophilia A, Haemophilia B, Haemophilia C)
6.2.2. By Product (Recombinant Coagulation Factor Concentrates, Plasma Derived Coagulation Factor Concentrate, Desmopressin, Antifibrinolytics Agents)
6.2.3. By Treatment(On-demand and Prophylaxis)
6.2.4. By Therapy (Replacement Therapy, ITI Therapy and Gene Therapy)
6.2.5. By Company (2020)
6.2.6. By Region
6.3. Product Market Map Product Market Map Product Market Map
4

• Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
7. Asia-Pacific Haemophilia Treatment Market Outlook Asia-Pacific Haemophilia Treatment Market Outlook Asia-Pacific Haemophilia Treatment Market Outlook Asia-Pacific Haemophilia Treatment Market Outlook Asia-Pacific Haemophilia Treatment Market Outlook
7.1. Market Size Forecast Market Size Forecast Market Size Forecast Market Size Forecast
7.1.1. By Value By Value By Value
7.2. Market Share Forecast Market Share Forecast Market Share Forecast Market Share Forecast
7.2.1. By Type By Type By Type
7.2.2. By Product By Product By Product
7.2.3. By Treatment By Treatment By Treatment
7.2.4. By Therapy By Therapy By Therapy
7.2.5. By Country By Country By Country
7.3. Asia-Pacific Country Analysis Asia-Pacific Country Analysis Asia-Pacific Country Analysis Asia-Pacific Country Analysis
7.3.1. China Haemophilia Treatment Market Outlook China Haemophilia Treatment Market Outlook China Haemophilia Treatment Market Outlook
7.3.1.1. Market Size Forecast Market Size Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share Forecast Market Share Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Product
7.3.1.2.3. By Treatment
7.3.1.2.4. By Therapy
5

• Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
7.3.2. India Haemophilia Treatment Market Outlook India Haemophilia Treatment Market Outlook India Haemophilia Treatment Market Outlook
7.3.2.1. Market Size Forecast Market Size Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share Forecast Market Share Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Product
7.3.2.2.3. By Treatment
7.3.2.2.4. By Therapy
7.3.3. Japan Haemophilia Treatment Market Outlook Japan Haemophilia Treatment Market Outlook Japan Haemophilia Treatment Market Outlook
7.3.3.1. Market Size Forecast Market Size Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share Forecast Market Share Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Product
7.3.3.2.3. By Treatment
7.3.3.2.4. By Therapy
6

• Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
7.3.4. South Korea Haemophilia Treatment Market Outlook South Korea Haemophilia Treatment Market Outlook South Korea Haemophilia Treatment Market Outlook
7.3.4.1. Market Size Forecast Market Size Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share Forecast Market Share Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Product
7.3.4.2.3. By Treatment
7.3.4.2.4. By Therapy
7.3.5. Australia Haemophilia Treatment Market Outlook Australia Haemophilia Treatment Market Outlook Australia Haemophilia Treatment Market Outlook
7.3.5.1. Market Size Forecast Market Size Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share Forecast Market Share Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Product
7.3.5.2.3. By Treatment
7.3.5.2.4. By Therapy
7

• Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
8. Europe Haemophilia Treatment Market Outlook Europe Haemophilia Treatment Market Outlook Europe Haemophilia Treatment Market Outlook Europe Haemophilia Treatment Market Outlook Europe Haemophilia Treatment Market Outlook
8.1. Market Size Forecast Market Size Forecast Market Size Forecast Market Size Forecast
8.1.1. By Value By Value By Value
8.2. Market Share Forecast Market Share Forecast Market Share Forecast Market Share Forecast
8.2.1. By Type By Type By Type
8.2.2. By Product By Product By Product
8.2.3. By Treatment By Treatment By Treatment
8.2.4. By Therapy By Therapy By Therapy
8.2.5. By Country By Country By Country
8.3. Europe Country Analysis Europe Country Analysis Europe Country Analysis Europe Country Analysis
8.3.1. France Haemophilia Treatment Market Outlook France Haemophilia Treatment Market Outlook France Haemophilia Treatment Market Outlook
8.3.1.1. Market Size Forecast Market Size Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share Forecast Market Share Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Product
8.3.1.2.3. By Treatment
8.3.1.2.4. By Therapy
8

• Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
8.3.2. Germany Haemophilia Treatment Market Outlook Germany Haemophilia Treatment Market Outlook Germany Haemophilia Treatment Market Outlook
8.3.2.1. Market Size Forecast Market Size Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share Forecast Market Share Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Product
8.3.2.2.3. By Treatment
8.3.2.2.4. By Therapy
8.3.3. United Kingdom Haemophilia Treatment Market Outlook United Kingdom Haemophilia Treatment Market Outlook United Kingdom Haemophilia Treatment Market Outlook United Kingdom Haemophilia Treatment Market Outlook
8.3.3.1. Market Size Forecast Market Size Forecast Market Size Forecast
8.3.3.1.1. By Value By Value
8.3.3.2. Market Share Forecast Market Share Forecast Market Share Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Product
8.3.3.2.3. By Treatment
8.3.3.2.4. By Therapy
9

• Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
8.3.4. Italy Haemophilia Treatment Market Outlook Italy Haemophilia Treatment Market Outlook Italy Haemophilia Treatment Market Outlook
8.3.4.1. Market Size Forecast Market Size Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share Forecast Market Share Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Product
8.3.4.2.3. By Treatment
8.3.4.2.4. By Therapy
8.3.5. Spain Haemophilia Treatment Market Outlook Spain Haemophilia Treatment Market Outlook Spain Haemophilia Treatment Market Outlook Spain Haemophilia Treatment Market Outlook
8.3.5.1. Market Size Forecast Market Size Forecast Market Size Forecast
8.3.5.1.1. By Value By Value
8.3.5.2. Market Share Forecast Market Share Forecast Market Share Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Product
8.3.5.2.3. By Treatment
8.3.5.2.4. By Therapy
10

• Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
9. North America Haemophilia Treatment Market Outlook North America Haemophilia Treatment Market Outlook North America Haemophilia Treatment Market Outlook North America Haemophilia Treatment Market Outlook North America Haemophilia Treatment Market Outlook
9.1. Market Size Forecast Market Size Forecast Market Size Forecast Market Size Forecast
9.1.1. By Value By Value By Value
9.2. Market Share Forecast Market Share Forecast Market Share Forecast Market Share Forecast
9.2.1. By Type By Type By Type
9.2.2. By Product By Product By Product
9.2.3. By Treatment By Treatment By Treatment
9.2.4. By Therapy By Therapy By Therapy
9.2.5. By Country By Country By Country
9.3. North America Country Analysis North America Country Analysis North America Country Analysis North America Country Analysis
9.3.1. United States Haemophilia Treatment Market Outlook United States Haemophilia Treatment Market Outlook United States Haemophilia Treatment Market Outlook
9.3.1.1. Market Size Forecast Market Size Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share Forecast Market Share Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Product
9.3.1.2.3. By Treatment
9.3.1.2.4. By Therapy
11

• Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
9.3.2. Canada Haemophilia Treatment Market Outlook Canada Haemophilia Treatment Market Outlook Canada Haemophilia Treatment Market Outlook
9.3.2.1. Market Size Forecast Market Size Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share Forecast Market Share Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Product
9.3.2.2.3. By Treatment
9.3.2.2.4. By Therapy
9.3.3. Mexico Haemophilia Treatment Market Outlook Mexico Haemophilia Treatment Market Outlook Mexico Haemophilia Treatment Market Outlook
9.3.3.1. Market Size Forecast Market Size Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share Forecast Market Share Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Product
9.3.3.2.3. By Treatment
9.3.3.2.4. By Therapy
12

• Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
10. South America Haemophilia Treatment Market Outlook South America Haemophilia Treatment Market Outlook South America Haemophilia Treatment Market Outlook South America Haemophilia Treatment Market Outlook South America Haemophilia Treatment Market Outlook
10.1. Market Size Forecast Market Size Forecast Market Size Forecast Market Size Forecast
10.1.1. By Value By Value By Value
10.2. Market Share Forecast Market Share Forecast Market Share Forecast Market Share Forecast
10.2.1. By Type By Type By Type
10.2.2. By Product By Product By Product
10.2.3. By Treatment By Treatment By Treatment
10.2.4. By Therapy By Therapy By Therapy
10.2.5. By Country By Country By Country
10.3. South America Country Analysis South America Country Analysis South America Country Analysis South America Country Analysis
10.3.1. Brazil Haemophilia Treatment Market Outlook Brazil Haemophilia Treatment Market Outlook Brazil Haemophilia Treatment Market Outlook
10.3.1.1. Market Size Forecast Market Size Forecast
10.3.1.1.1 By Value
10.3.1.2. Market Share Forecast Market Share Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Product
10.3.1.2.3. By Treatment
10.3.1.2.4. By Therapy
13

• Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
10.3.2. Argentina Haemophilia Treatment Market Outlook Argentina Haemophilia Treatment Market Outlook Argentina Haemophilia Treatment Market Outlook
10.3.2.1. Market Size Forecast Market Size Forecast
10.3.2.1.1 By Value
10.3.2.2. Market Share Forecast Market Share Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Product
10.3.2.2.3. By Treatment
10.3.2.2.4. By Therapy
10.3.3. Colombia Haemophilia Treatment Market Outlook Colombia Haemophilia Treatment Market Outlook Colombia Haemophilia Treatment Market Outlook
10.3.3.1. Market Size Forecast Market Size Forecast
10.3.3.1.1 By Value
10.3.3.2. Market Share Forecast Market Share Forecast
10.3.3.2.1. By Type
10.3.2.2.2. By Product
10.3.2.2.3. By Treatment
10.3.2.2.4. By Therapy
14

• Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
11. Middle East Africa Haemophilia Treatment Market Outlook Middle East Africa Haemophilia Treatment Market Outlook Middle East Africa Haemophilia Treatment Market Outlook Middle East Africa Haemophilia Treatment Market Outlook Middle East Africa Haemophilia Treatment Market Outlook
11.1. Market Size Forecast Market Size Forecast Market Size Forecast Market Size Forecast
11.1.1. By Value By Value By Value
11.2. Market Share Forecast Market Share Forecast Market Share Forecast Market Share Forecast
11.2.1. By Type By Type By Type
11.2.2. By Product By Product By Product
11.2.3. By Treatment By Treatment By Treatment
11.2.4. By Therapy By Therapy By Therapy
11.2.5. By Country By Country By Country
11.3. Middle East Africa Country Analysis Middle East Africa Country Analysis Middle East Africa Country Analysis Middle East Africa Country Analysis
11.3.1 Saudi Arabia Haemophilia Treatment Market Outlook Saudi Arabia Haemophilia Treatment Market Outlook Saudi Arabia Haemophilia Treatment Market Outlook
11.3.1.1. Market Size Forecast Market Size Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share Forecast Market Share Forecast
11.3.1.2.1. By Type
11.3.1.2.2. By Product
11.3.1.2.3. By Treatment
11.3.1.2.4. By Therapy
15

• Table of Contents

S. No. Contents Contents Contents Contents Contents Page No.
11.3.2. UAE Haemophilia Treatment Market Outlook UAE Haemophilia Treatment Market Outlook UAE Haemophilia Treatment Market Outlook
11.3.2.1. Market Size Forecast Market Size Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share Forecast Market Share Forecast
11.3.2.2.1. By Type
11.3.2.2.2. By Product
11.3.2.2.3. By Treatment
11.3.2.2.4. By Therapy
11.3.3. South Africa Haemophilia Treatment Market Outlook South Africa Haemophilia Treatment Market Outlook South Africa Haemophilia Treatment Market Outlook
11.3.3.1. Market Size Forecast Market Size Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share Forecast Market Share Forecast
11.3.3.2.1. By Type
11.3.3.2.2. By Product
11.3.3.2.3. By Treatment
11.3.3.2.4. By Therapy
16

• Table of Contents

S. No. Contents Contents Contents Contents Page No.
12. Market Dynamics Market Dynamics Market Dynamics
12.1. Drivers Drivers
12.2. Challenges Challenges
13. Market Trends Developments Market Trends Developments Market Trends Developments Market Trends Developments
14. Competitive Landscape Competitive Landscape Competitive Landscape Competitive Landscape
14.1. Competitive Outlook Competitive Outlook Competitive Outlook
14.2. Company Profiles Company Profiles
14.2.1. Company Details Company Details
14.2.2. Product Types Services Product Types Services
14.2.3. Financials (As Reported) Financials (As Reported)
14.2.4. Key Market Focus Geographical Presence Key Market Focus Geographical Presence
14.2.5. Recent Developments Recent Developments
14.2.6. Key Management Personnel Key Management Personnel
15. Strategic Recommendations Strategic Recommendations Strategic Recommendations
16. About Us Disclaimer About Us Disclaimer About Us Disclaimer
17
RESEARCH METHODOLOGY
18

• Research Methodology

Market Profiling
Data Analysis
Data Collection
Data Validation
Developing List of Respondents
Formulating Questionnaire
In-depth secondary research was conducted to
determine top players in the global haemophilia
treatment market, overall market size and
segmental market size.
The data was scrutinized using MS-Excel,
statistical tools and internal proprietary
database to obtain qualitative and quantitative
insights about the global haemophilia treatment
market.
Data obtained as a result of primary and
secondary research was validated through rigorous
triangulation.
TechSci conducted interviews with industry
experts and industry players for data collection
and verification.
In order to conduct industry experts interviews,
TechSci formulated a detailed discussion guide.
List of industry players and industry specialists
was developed.
Primary Research
Desk Research
Company Analysis

• Recent Developments
• Market Changing Aspects/Dynamics
• Government Policies
• Conclusion

• Market Participants
• Key Strengths

• Identifying Key Opinion Leaders
• Questionnaire Design
• In-depth Interviews

19

• Research Methodology

• Baseline Methodology
• Our dedicated team of industry experts has
  monitored and analyzed various aspects of the
  global haemophilia treatment market. The team has
  analyzed the outlook of various segments of this
  market, while considering the major influencing
  factors such as haemophilia treatment. The study
  includes market forecasting, which would enable
  our clients to take better decisions while
  planning their strategy to achieve sustainability
  in the global haemophilia treatment market.
• Methodology Followed for Calculation of Market
  Size
• Market Size by Value Market size, in terms of
  value , for the year 2020 was calculated based on
  information collected through exhaustive
  secondary research and primary surveys, with
  various key opinion leaders/stakeholders, such as
  haemophilia treatment companies, channel
  partners, market influencers end-users,
  industry experts, and other industry
  participants.
• The team interviewed more than 15 20
  haemophilia treatment companies, 100 120
  end-users, and 15 20 industry experts and other
  value chain stakeholders in the global
  haemophilia treatment market to obtain the
  overall market size from 2016 to 2020, which was
  validated by the Delphi technique. Taking
  standard deviation into consideration, the market
  size was averaged out, to arrive at the market
  size data during 2016-2020.

20

• Research Methodology

• Respondents were asked about the current and
  future market growth rates, market shares by
  type, by product, by treatment, by therapy, by
  company and by region. Removing the outlier
  responses, the geometric mean of growth estimates
  and provider wise revenue shares generated across
  various segments were considered, to arrive at
  the final revenue shares. Revenue shares
  generated across various segments were further
  triangulated from other stakeholders.
• Methodology Followed for Calculation of Market
  Shares
• Market share by type, by product, by treatment,
  by therapy, by company and by region were
  calculated based on the responses received
  through primary surveys with industry experts, in
  which the respondents were asked about the market
  shares or revenue generated from various segments
  of haemophilia treatment markets. The final
  shares were calculated by taking the geometric
  mean of the responses gathered from key opinion
  leaders after eliminating the outliers.
• Methodology Followed for Forecasting
• TechSci Research performed periodical checks on
  data collected through the surveys with logic
  checks and analyzed the survey results in
  SPSS/Tableau Software.
• Data triangulation techniques were applied to
  fill the gaps and to present a more meaningful
  picture of the market. To forecast global
  haemophilia treatment market, TechSci Research
  used various forecast techniques such as
• Moving Average
• Time Series Analysis
• Regression Analysis
• Econometric and Judgmental Analysis

21

• Research Methodology

TechSci Research used its own forecast tool,
which is based on the growth of various allied
industries in respective regions. TechSci
Research also used the impact analysis during
short, medium and long term period to estimate
the demand and to reach accurate market numbers.
It should be noted that the figures compiled are
only for the organized market including market
share data. The currency used in the report is
the United States Dollar (USD), with the market
size indicated in USD million.
Partial List of Companies Interviewed Key Secondary Sources
Novo Nordisk A/S F. Hoffmann-La Roche AG Bayer AG Pfizer, Inc. Takeda Pharmaceutical Company Sanofi S.A. CSL Behring LLC BioMarin Pharmaceutical Inc. Octapharma AG Sangamo Therapeutics Inc. Eagle Pharmaceuticals Inc. Baxter International, Inc. Grifols SA Biogen Idec, Inc. Alnylam Pharmaceuticals Inc. World Bank TechSci Research Proprietary Database Knowledge Repository Company Annual Reports Industry Magazines Industry Reports News Dailies Credible Paid Databases
22

• Industry Brief

Increasing number of haemophilic patients
worldwide and increased diagnosis rate across the
globe to drive global haemophilia treatment
market. According to TechSci Research
report, Global Haemophilia Treatment Market By
Type (Haemophilia A, Haemophilia B, Haemophilia
C), By Product (Recombinant Coagulation Factor
Concentrates, Plasma Derived Coagulation Factor
Concentrate, Desmopressin, Antifibrinolytics
Agents), By Treatment (On-demand and
Prophylaxis), By Therapy (Replacement Therapy,
ITI therapy and Gene Therapy), By Region,
Competition, Forecast Opportunities, 2026,
global haemophilia treatment market was valued at
USD13906.45 million in 2020 and is forecast to
reach USD24205.39 million in 2026 by registering
a CAGR of 9.06 during the forecast period.
Increasing number of haemophilic patients
worldwide is one of the major factors accounting
for the growth of global haemophilia treatment
market. Moreover, upsurge in the use of
prophylactic treatment for haemophilia is
expected to bode well for the growth of global
haemophilia treatment market through the forecast
period. In addition to this, supportive
initiatives plan by governments worldwide in
order to commence early screening of neonates is
expected to positively influence the growth of
global haemophilia treatment market in the years
to come. Also, growing severity with the genetic
evolution, is making headway for the growth of
global haemophilia treatment market. Furthermore,
rising availability of Haemophilia drugs is also
contributing to increasing market growth.
However, there are certain factors that might
hamper the growth of global haemophilia treatment
market over the coming years including high cost
of recombinant products, stringent government
regulations and serious adverse effects
associated with plasma derived products. Global
haemophilia treatment market can be segmented
based on type, product, treatment, therapy,
company, and region. Considering the product, the
market is fragmented into recombinant coagulation
factor concentrates, plasma derived coagulation
factor concentrate, desmopressin, and
antifibrinolytics agents. Here, the recombinant
coagulation factor concentrates segment dominated
the global haemophilia treatment market in terms
of largest market share in 2020 and is further
anticipated to maintain its dominance during the
forecast period as well, which can be accredited
to increase in production of recombinant factor
concentrates to treat Haemophilia coupled with
its better outcome as compared to plasma derived
coagulation factor concentrate. Moreover,
enhanced safety of replacement therapy by using
recombinant factor concentrates, is further
boosting the segmental growth. In terms of
treatment, the market is categorized into
on-demand and prophylaxis. Out of which, the
prophylaxis treatment is forecast to register
highest growth in the years to come on account of
its efficiency and better end results.
Additionally, preference for long-term
prophylaxis treatment to prevent chronic
arthropathy and joint bleeding in patients with
severe haemophilia, is further contributing to
the growth of the segment. Novo Nordisk A/S, F.
Hoffmann-La Roche AG, Bayer AG, Pfizer, Inc.,
Takeda Pharmaceutical Company, Sanofi S.A., CSL
Behring LLC, BioMarin Pharmaceutical Inc.,
Octapharma AG, Sangamo Therapeutics Inc., Eagle
Pharmaceuticals Inc., Baxter International, Inc.,
Grifols SA, Biogen Idec, Inc., Alnylam
Pharmaceuticals Inc., among others are the
leading players operating in global haemophilia
treatment market. The players are adopting
several growth strategies to enhance the market
scenario of haemophilia treatment. Other
competitive strategies include mergers
acquisitions agreements, partnerships, and
collaborations and expansions to diverse their
product portfolio in order to strengthen their
market position. North America held the largest
market share in 2020 and is further projected to
dominate the global haemophilia treatment market
during the next five years as well. This can be
ascribed to presence of favorable healthcare
reimbursement and insurance policies in the
region. Furthermore, growing demand and adoption
rate of haemophilia medications is also
contributing to the growing trend. Additionally,
better diagnostic techniques available in the
region is anticipated to bolster the growth of
global haemophilia treatment market over the
coming years. Besides, Asia Pacific is projected
to register the highest growth rate during the
forecast period on account of early diagnosis of
the diseases in growing economies such as Japan
and India, along with rising per capita use of
therapies for factor VIII and IX deficiency.,
said Mr. Karan Chechi, Research Director with
TechSci Research, a research based global
management consulting firm.
23

• Sample Data - Snapshot

Global Haemophilia Treatment Market Size, By
Value (USD Million), 2016-2026F
North America Haemophilia Treatment Market
Share, By Type, By Value, 20162026F
United States Haemophilia Treatment Market Share,
By Therapy, By Value, 20162026F
United States Haemophilia Treatment Market Share,
By Treatment, By Value, 20162026F
24

• Report Ordering

Report Name GLOBAL HAEMOPHILIA TREATMENT
MARKET FORECAST OPPORTUNITIES 2016 2026
License Type Price
Single User License 4900
Multi-User License 5900
Custom Research License 8900
To View Sample OR Purchase Report  
25
About Us Disclaimer
TechSci Research is a global market research and
consulting company with offices in the US, UK and
India. TechSci Research provides market research
reports in number of areas to organizations. The
company uses innovative business models that
focus on improving productivity, while ensuring
creation of high-quality reports. The proprietary
forecasting models use various analyses of both
industry-specific and macroeconomic variables on
a state-by-state basis to produce a unique
bottom-up model of a country, regional and
global industry prospects. Combined with the
detailed analysis of company activity and
industry trends, the result is a uniquely rich
evaluation of the opportunities available in the
market.
Related Reports

• Precision Dosing Market - Global Industry Size,
  Share, Trends, Competition, Opportunity and
  Forecast, Segmented By Patient Type (Pediatrics,
  Geriatrics, Patients on Polypharmacy, Patients
  with End Organ Dysfunction, Others), By Tools
  (Physiologically-Based Pharmacokinetic (PBPK)
  Modeling v/s Non-Linear Mixed Effects (NLME)
  Modeling), By Software (Web-Based v/s
  Desktop-Based), By Drug Class (Antibiotics,
  Antimycotics, Immunosuppressives, Antiepileptics,
  Antitumoral Drugs, Antidepressants, Others), By
  Region 2016-2026
• India NIPAH Virus Diagnostics Market By Test Type
  (RT-PCR v/s ELISA), By Sample (Throat Nasal
  Swab, Urine, Blood, Others), By End User
  (Hospitals Clinics, Diagnostics Laboratories,
  Others), By Region, Competition Forecast
  Opportunities, FY2027

TechSci Research North America 708 Third
Avenue, Manhattan, New York, United States Tel
1- 646- 360- 1656 Email sales_at_techsciresearch.co
m www.techsciresearch.com
TechSci Research Europe 54, Old brook,
Bretton, Peterborough, United Kingdom Email
sales_at_techsciresearch.com www.techsciresearch.com
TechSci Research Asia-Pacific B 44, Sector
57, Noida, National Capital Region, U.P. -
India Tel [phone] Email
sales_at_techsciresearch.com www.techsciresearch.com
Disclaimer
The contents of this report are based on
information generally available to the public
from sources believed to be reliable. No
representation is made that it is timely,
accurate or complete. TechSci Research has taken
due care and caution in compilation of data as
this has been obtained from various sources
including which it considers reliable and
firsthand. However, TechSci Research does not
guarantee the accuracy, adequacy or completeness
of any information and it is not responsible for
any errors or omissions or for the results
obtained from the use of such information and
especially states that it has no financial
liability whatsoever to the subscribers / users
of this report. The information herein, together
with all estimates and forecasts, can change
without notice. All the figures provided in this
document are indicative of relative market size
and are strictly for clients internal
consumption. Usage of the same for purpose other
than internal will require prior approval of
TechSci Research.